What is the recommended treatment for a Corynebacterium urealyticum urinary infection?

Treatment of Corynebacterium urealyticum Urinary Tract Infection

Vancomycin is the treatment of choice for Corynebacterium urealyticum urinary tract infections, typically requiring 7-14 days of therapy, with surgical intervention (endoscopic debridement) often necessary for encrusted cystitis or when antibiotic therapy alone fails.

Antibiotic Selection

C. urealyticum is a multidrug-resistant, urease-producing organism that requires specific antimicrobial therapy:

• Vancomycin remains universally susceptible (100% susceptibility) and is the first-line agent 1
• Linezolid and rifampicin show good activity as alternatives (MIC90 = 1 and 0.4 mg/L respectively) 1
• Teicoplanin has been successfully used in case reports 2
• Avoid ampicillin (100% resistance), erythromycin (95% resistance), and fluoroquinolones (95% resistance) 1

Treatment Duration and Approach

Standard UTI Without Encrustation

• 7-14 days of vancomycin therapy 3, 4
• For males, consider 14 days when prostatitis cannot be excluded (following general complicated UTI principles from 5)

Encrusted Cystitis (Critical Distinction)

This is where C. urealyticum becomes particularly problematic:

Antibiotic therapy alone frequently fails because:

• Mucosal encrustation and infectious calculi act as persistent infection foci 3
• Struvite stones form rapidly due to urease production, creating alkaline urine (pH 7.5-9.0) 6
• Bacteria colonize within encrustations, reducing antibiotic penetration 3

Combined approach required:

1. Surgical debridement via cystoscopy to remove encrustations and bladder stones 3
2. Followed by 2 weeks of vancomycin therapy 3
3. Consider intravesical vancomycin for resistant cases or when systemic therapy fails 7

Clinical Recognition

Look for these characteristic features:

• Alkaline urine (pH 7.5-9.0) with triple phosphate crystals on urinalysis 6
• History of prolonged catheterization, multiple hospitalizations, or urological procedures 3, 4
• Recurrent UTIs despite appropriate antibiotic therapy
• Immunocompromised or multimorbid patients 3

Critical Pitfalls

Do not dismiss as contaminant: While Corynebacterium species are often skin flora, C. urealyticum in patients with risk factors represents true infection 4

Do not rely on standard complicated UTI regimens: The EAU guidelines 5 recommend fluoroquinolones, cephalosporins, and aminoglycosides for complicated UTIs, but C. urealyticum shows 95-100% resistance to these agents 1. This organism requires pathogen-specific therapy.

Do not treat with antibiotics alone if encrustation present: Multiple case reports demonstrate treatment failure with systemic antibiotics alone when encrustations exist 3, 2. Endoscopic evaluation and debridement are essential for cure.

Practical Algorithm

1. Identify the organism: Slow-growing gram-positive pleomorphic rods with alkaline urine and triple phosphate crystals
2. Assess for encrustation: Perform cystoscopy if recurrent symptoms, bladder stones suspected, or prior antibiotic failure
3. If no encrustation: Vancomycin 7-14 days (IV or IM)
4. If encrustation present: Endoscopic debridement + vancomycin 14 days
5. If systemic therapy fails: Add intravesical vancomycin 7
6. Remove/replace catheters when possible, as catheterization is a major risk factor

The multidrug resistance pattern (97.5% of isolates) 1 and unique pathogenic mechanism of alkalinization with encrustation distinguish this organism from typical uropathogens, necessitating this specialized approach rather than standard complicated UTI management.